Programmed cell death serves as a critical defense mechanism during viral infection. The kinases RIPK1 and RIPK3, central regulators of programmed cell death pathways, undergo precise modulation through various post-translational modifications. The ADP-ribosylation of RIPK1/3 has been documented, but the functional consequences of this modification on kinase activity and downstream cell death signaling remain elusive.
PARP family proteins are ADP-ribosyltransferases that can modify target proteins with ADP-ribose. They have recently emerged as important regulators of antiviral immunity.
In a study published in the Proceedings of the National Academy of Sciences, a research team led by Prof. Yuan Junying at the Shanghai Institute of Organic Chemistry of the Chinese Academy of Sciences revealed how PARP12, a mono-ADP-ribosyltransferase, modulates cell fate decisions during viral infection.
Through systematic analysis of the mass spectrometry data, researchers identified PARP12 as a novel regulator of cell death pathways.
They demonstrated that PARP12 specifically mono-ADP-ribosylates (MARylates) RIPK1 and RIPK3, promoting RIPK1-RIPK3-dependent necroptosis while simultaneously suppressing RIPK1-caspase-8-mediated apoptosis. Besides, they found that PARP12 negatively regulates interferon-stimulated gene expression in a RIPK1-dependent manner.
The physiological relevance of these findings was confirmed in vivo using PARP12-deficient mice. Following influenza virus infection, PARP12 knockout mice exhibited significantly improved survival outcomes and attenuated weight loss compared to wild-type controls.
Moreover, histopathological examination revealed reduced pulmonary necroptosis and lower viral titers in PARP12-deficient animals, establishing PARP12 as a critical molecular switch governing cell death and immune responses during viral infection.
The findings of this study not only deepen our understanding of host-virus interactions but also suggest PARP12 as a potential therapeutic target for influenza and other viral infections.
More information:
Xin Huang et al, PARP12-mediated mono-ADP-ribosylation as a checkpoint for necroptosis and apoptosis, Proceedings of the National Academy of Sciences (2025). DOI: 10.1073/pnas.2426660122
Provided by
Chinese Academy of Sciences
Citation:
Researchers reveal new mechanism of PARP12 in regulating cell death and antiviral immunity (2025, June 12)
retrieved 12 June 2025
from https://phys.org/news/2025-06-reveal-mechanism-parp12-cell-death.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
part may be reproduced without the written permission. The content is provided for information purposes only.
